Citation: Sr. Benedetto et al., Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs, AM J HEAL S, 57(19), 2000, pp. 1778-1785
Authors:
Goldfarb, SD
Duncan, BS
Dans, PE
Sloan, AS
Citation: Sd. Goldfarb et al., HMO direct costs and health care resource use after implementation of a monthly limit on sumatriptan, AM J HEAL S, 56(21), 1999, pp. 2206-2210
Authors:
Amin, SP
Mullins, CD
Duncan, BS
Blandford, L
Citation: Sp. Amin et al., Direct health care costs for treatment of diabetes mellitus and hypertension in an IPA-group-model HMO, AM J HEAL S, 56(15), 1999, pp. 1515-1520